Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

LB322 (Bcl-2 from ATG to -3934) Citations (7)

Plasmid Article: A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells.
Heckman CA, Mehew JW, Ying GG, Introna M, Golay J, Boxer LM J Biol Chem. 2000 Mar 3. 275(9):6499-508.
PubMed Journal

Articles Citing LB322 (Bcl-2 from ATG to -3934)

TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. Dittmer S, Kovacs Z, Yuan SH, Siszler G, Kogl M, Summer H, Geerts A, Golz S, Shioda T, Methner A. J Cell Sci. 2011 Jan 15;124(Pt 2):252-60. doi: 10.1242/jcs.068759. Epub 2010 Dec 15. PubMed
DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells. Zhao R, Han C, Eisenhauer E, Kroger J, Zhao W, Yu J, Selvendiran K, Liu X, Wani AA, Wang QE. Mol Cancer Res. 2014 Mar;12(3):370-80. doi: 10.1158/1541-7786.MCR-13-0281. Epub 2013 Nov 18. PubMed
RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2. Wang X, Zhou M, Fu Y, Sun T, Chen J, Qin X, Yu Y, Jia J, Chen C. PLoS One. 2016 Mar 23;11(3):e0152142. doi: 10.1371/journal.pone.0152142. eCollection 2016. PubMed
MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1. Sun YP, Lu F, Han XY, Ji M, Zhou Y, Zhang AM, Wang HC, Ma DX, Ji CY. Oncotarget. 2016 Mar 22. doi: 10.18632/oncotarget.8252. PubMed
Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex. Dutta D, Debnath M, Muller D, Paul R, Das T, Bessi I, Schwalbe H, Dash J. Nucleic Acids Res. 2018 Jun 20;46(11):5355-5365. doi: 10.1093/nar/gky385. PubMed
Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4. Kim S, Ko D, Lee Y, Jang S, Lee Y, Lee IY, Kim S. Sci Rep. 2019 Jul 10;9(1):10003. doi: 10.1038/s41598-019-46447-7. PubMed
Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity. Kavazovic I, Han H, Balzaretti G, Slinger E, Lemmermann NAW, Ten Brinke A, Merkler D, Koster J, Bryceson YT, de Vries N, Jonjic S, Klarenbeek PL, Polic B, Eldering E, Wensveen FM. PLoS Biol. 2020 Mar 17;18(3):e3000648. doi: 10.1371/journal.pbio.3000648. eCollection 2020 Mar. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.